FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307920120> ?p ?o ?g. }

• W4307920120 abstract "There is a lack of efficacious topical treatments for patients suffering from psoriatic nail disease (PND). We investigated the efficacy of Calcipotriol-Betamethasone Dipropionate (Cal/BD) foam with and without ablative fractional laser (AFL) in patients with PND. A total of 144 nails from 11 patients were treated in a 24-week long, open-label, randomized, intra-patient controlled proof-of-concept hybrid trial. In addition to daily Cal/BD foam application, half of each patient's psoriatic nails were randomized to receive optical coherence tomography (OCT)-guided AFL treatment at baseline, 6-, and 12-week follow-ups. In-clinic assessment (N-NAIL), patient-reported outcomes (PROMs), and drug consumption were supplemented by remote evaluation of 15 subclinical OCT features, smartphone app-based safety monitoring, and photo-based assessment (NAPSI). After 24 weeks of Cal/BD foam treatment, patients achieved a significant improvement (p < 0.001) in both clinical (N-NAIL -76%, NAPSI -68%) and subclinical (OCT -43%) PND severity as well as a 71% reduction in PROMs. AFL-assisted Cal/BD treatment led to higher clinical (N-NAIL -85%, NAPSI -78%) and OCT-assessed (-46%) reduction of PND signs than Cal/BD alone (N-NAIL -66%, NAPSI -58%, OCT -37%), but did not reach statistical significance. Smartphone app images documented adverse events and mild local skin reactions, particularly erythema (75%), laser-induced swelling (28%), and crusting (27%). This hybrid trial demonstrated a reduction in clinical NAPSI and N-NAIL scores, subclinical OCT features, and PROMs, suggesting that Cal/BD foam is a safe and efficacious treatment for PND. Larger trials are warranted to prove the clinical benefit of AFL pretreatment as a Cal/BD delivery enhancer." @default.
• W4307920120 created "2022-11-06" @default.
• W4307920120 creator A5012506687 @default.
• W4307920120 creator A5015385519 @default.
• W4307920120 creator A5036800969 @default.
• W4307920120 creator A5040426463 @default.
• W4307920120 creator A5040518221 @default.
• W4307920120 creator A5041212876 @default.
• W4307920120 creator A5065554563 @default.
• W4307920120 creator A5080269322 @default.
• W4307920120 creator A5086669701 @default.
• W4307920120 date "2022-11-23" @default.
• W4307920120 modified "2023-09-26" @default.
• W4307920120 title "Investigating the efficacy and safety of calcipotriol/betamethasone dipropionate foam and laser microporation for psoriatic nail disease—A hybrid trial using a smartphone application, optical coherence tomography, and <scp>patient‐reported</scp> outcome measures" @default.
• W4307920120 cites W1488459040 @default.
• W4307920120 cites W154747979 @default.
• W4307920120 cites W1569848357 @default.
• W4307920120 cites W1728542723 @default.
• W4307920120 cites W1964432323 @default.
• W4307920120 cites W1976060052 @default.
• W4307920120 cites W1986989304 @default.
• W4307920120 cites W1993506331 @default.
• W4307920120 cites W2010347549 @default.
• W4307920120 cites W2028947561 @default.
• W4307920120 cites W2029499820 @default.
• W4307920120 cites W2033536993 @default.
• W4307920120 cites W2033897328 @default.
• W4307920120 cites W2036266603 @default.
• W4307920120 cites W2052785171 @default.
• W4307920120 cites W2059354317 @default.
• W4307920120 cites W2059767692 @default.
• W4307920120 cites W2064146223 @default.
• W4307920120 cites W2081962645 @default.
• W4307920120 cites W2082817348 @default.
• W4307920120 cites W2093274439 @default.
• W4307920120 cites W2127025846 @default.
• W4307920120 cites W2137149849 @default.
• W4307920120 cites W2151715175 @default.
• W4307920120 cites W2407181477 @default.
• W4307920120 cites W2575085857 @default.
• W4307920120 cites W2744155321 @default.
• W4307920120 cites W2767091119 @default.
• W4307920120 cites W2781900432 @default.
• W4307920120 cites W2803134458 @default.
• W4307920120 cites W2803266532 @default.
• W4307920120 cites W2803372522 @default.
• W4307920120 cites W2811445178 @default.
• W4307920120 cites W2901917814 @default.
• W4307920120 cites W2944434778 @default.
• W4307920120 cites W2980495364 @default.
• W4307920120 cites W2981868809 @default.
• W4307920120 cites W2982413031 @default.
• W4307920120 cites W3004917327 @default.
• W4307920120 cites W3010102662 @default.
• W4307920120 cites W3014163363 @default.
• W4307920120 cites W3043112937 @default.
• W4307920120 cites W3046265123 @default.
• W4307920120 cites W3047905044 @default.
• W4307920120 cites W3121999759 @default.
• W4307920120 cites W3127015827 @default.
• W4307920120 cites W3199803713 @default.
• W4307920120 cites W3205563769 @default.
• W4307920120 cites W4221018167 @default.
• W4307920120 cites W4224242083 @default.
• W4307920120 cites W4253184167 @default.
• W4307920120 cites W4307920120 @default.
• W4307920120 cites W3132192323 @default.
• W4307920120 doi "https://doi.org/10.1111/dth.15965" @default.
• W4307920120 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36321647" @default.
• W4307920120 hasPublicationYear "2022" @default.
• W4307920120 type Work @default.
• W4307920120 citedByCount "1" @default.
• W4307920120 countsByYear W43079201202022 @default.
• W4307920120 crossrefType "journal-article" @default.
• W4307920120 hasAuthorship W4307920120A5012506687 @default.
• W4307920120 hasAuthorship W4307920120A5015385519 @default.
• W4307920120 hasAuthorship W4307920120A5036800969 @default.
• W4307920120 hasAuthorship W4307920120A5040426463 @default.
• W4307920120 hasAuthorship W4307920120A5040518221 @default.
• W4307920120 hasAuthorship W4307920120A5041212876 @default.
• W4307920120 hasAuthorship W4307920120A5065554563 @default.
• W4307920120 hasAuthorship W4307920120A5080269322 @default.
• W4307920120 hasAuthorship W4307920120A5086669701 @default.
• W4307920120 hasBestOaLocation W43079201202 @default.
• W4307920120 hasConcept C113280763 @default.
• W4307920120 hasConcept C126322002 @default.
• W4307920120 hasConcept C141071460 @default.
• W4307920120 hasConcept C16005928 @default.
• W4307920120 hasConcept C168563851 @default.
• W4307920120 hasConcept C191897082 @default.
• W4307920120 hasConcept C192562407 @default.
• W4307920120 hasConcept C197934379 @default.
• W4307920120 hasConcept C2776009542 @default.
• W4307920120 hasConcept C2777852167 @default.
• W4307920120 hasConcept C2779121184 @default.
• W4307920120 hasConcept C2779800615 @default.
• W4307920120 hasConcept C2780564577 @default.
• W4307920120 hasConcept C535046627 @default.
• W4307920120 hasConcept C71924100 @default.
• W4307920120 hasConceptScore W4307920120C113280763 @default.

• next